68 related articles for article (PubMed ID: 12110908)
1. Construction and Characterization of a Mutant of Single-chain Urokinase-type Plasminogen Activator Ser(175)-His(187)-mscu-PA.
Xue YM; Zhu H; Shi W; Liu W; Liu JN; Ma Z
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(1):26-30. PubMed ID: 12110908
[TBL] [Abstract][Full Text] [Related]
2. Construction of Urokinase Mutant Glu154-mtcu-PA and Characterization of Its Properties.
Peng GH; Ma Z; Xue YM; Chen YH; Zhu DX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 1997; 29(6):547-552. PubMed ID: 12215767
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
de Munk GA; Groeneveld E; Rijken DC
Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis at Pro309 of single-chain urokinase-type plasminogen activator alters its catalytic properties.
Sun Z; Liu JN
Proteins; 2005 Dec; 61(4):870-7. PubMed ID: 16231330
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
Fleury V; Lijnen HR; Anglés-Cano E
J Biol Chem; 1993 Sep; 268(25):18554-9. PubMed ID: 8103046
[TBL] [Abstract][Full Text] [Related]
7. Assay method for single-chain urokinase-type plasminogen activator.
Matsuo O; Ueshima S; Okada K; Fukao H; Ohgaki M; Watanabe R; Arimura H
Hematol Pathol; 1989; 3(3):137-42. PubMed ID: 2531734
[TBL] [Abstract][Full Text] [Related]
8. Differential detection of single-chain and two-chain urokinase-type plasminogen activator by a new immunoadsorbent-amidolytic assay (IAA).
Corti A; Nolli ML; Cassani G
Thromb Haemost; 1986 Dec; 56(3):407-10. PubMed ID: 3105110
[TBL] [Abstract][Full Text] [Related]
9. Mutation of Arg154 to Gly154 in urokinase augments its fibrin-specificity.
Peng G; Ma Z; Kuai L; Zhu D
Biochem Mol Biol Int; 1997 Apr; 41(5):887-94. PubMed ID: 9137818
[TBL] [Abstract][Full Text] [Related]
10. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.
Braat EA; Nauland U; Dooijewaard G; Rijken DC
Thromb Haemost; 1996 Jun; 75(6):908-14. PubMed ID: 8822585
[TBL] [Abstract][Full Text] [Related]
11. A site-directed mutagenesis of pro-urokinase which substantially reduces its intrinsic activity.
Liu JN; Tang W; Sun ZY; Kung W; Pannell R; Sarmientos P; Gurewich V
Biochemistry; 1996 Nov; 35(45):14070-6. PubMed ID: 8916892
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activator.
Ueshima S; Holvoet P; Lijnen HR; Nelles L; Seghers V; Collen D
Thromb Haemost; 1994 Jan; 71(1):134-40. PubMed ID: 8165632
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu).
Lijnen HR; Van Hoef B; Nelles L; Collen D
J Biol Chem; 1990 Mar; 265(9):5232-6. PubMed ID: 1969415
[TBL] [Abstract][Full Text] [Related]
14. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator.
Lijnen HR; Van Hoef B; Collen D
Biochim Biophys Acta; 1986 Dec; 884(3):402-8. PubMed ID: 3778931
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
Wolf BB; Vasudevan J; Henkin J; Gonias SL
J Biol Chem; 1993 Aug; 268(22):16327-31. PubMed ID: 8393859
[TBL] [Abstract][Full Text] [Related]
16. [Single-chain urokinase-type plasminogen activator (scu-PA) purification by immuno-affinity chromatography].
Gao LH; Hu XW; Wu QF; Xiao CZ; Xu ZP; Zhang ZG
Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):356-9. PubMed ID: 12192874
[TBL] [Abstract][Full Text] [Related]
17. [Characterization of urokinase type plasminogen activator modified by phenylglyoxal].
Mukhametova LI; Aĭsina RB; Lomakina GIu; Varfolomeev SD
Bioorg Khim; 2002; 28(4):308-14. PubMed ID: 12197387
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of recombinant human micro-plasminogen.
Ma Z; Lu W; Wu S; Chen J; Sun Z; Liu JN
Biotechnol Lett; 2007 Apr; 29(4):517-23. PubMed ID: 17206368
[TBL] [Abstract][Full Text] [Related]
19. Differential reactivity of Glu-Gly-Arg-CH2Cl, a synthetic urokinase inhibitor, with single-chain and two-chain forms of urokinase-type plasminogen activator.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1987 Jan; 162(2):351-6. PubMed ID: 3803392
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: an improved fibrinolytic agent targeted to phospholipid-containing thrombi.
Tanaka K; Einaga K; Tsuchiyama H; Tait JF; Fujikawa K
Biochemistry; 1996 Jan; 35(3):922-9. PubMed ID: 8547274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
